Work with us
By joining Lonza, you’ll get to work with some of the world’s top experts in the space, while developing advanced therapies with a potentially life-saving outcome.
Behnam Ahmadian Baghbaderani
Global Head of Process Development
Services provided at this site
Our 300,000 square foot facility is our US center of excellence for process development activities of cell therapies, gene therapies and viral vectors. The site includes large research and development laboratories dedicated to developing future cell and gene therapies innovations and technologies. In 2021, Lonza Houston was officially approved for commercial production of a gene therapy by the FDA.
Many of our customers start process development activities in the process development laboratories, before naturally transitioning to the manufacturing floor into one of our cGMP suites located under the same roof. We purposefully built the facility with future capacity in mind to enable scale-up manufacturing in line with our customer’s needs, so that, together, we can make more therapies available to patients.
- Flexible: our flexible suite set up can be readily adapted based on your individual processes.
- Single use: we employ single-use disposables in all of our manufacturing processes. Additionally, we have multiple parallel GMP viral vector trains and cell therapy suites that have independent air handling units, ensuring maintenance can be performed without affecting other suites.
- Able to serve a large number of patients: fully expanded, our footprint is capable of supporting more than 200 clinical and commercial viral vector cGMP batches annually.
- Supporting a wide variety of cell and viral vector types: the full range of services offered can support a wide selection of cell and virus types, such as T-cells, dendritic cells, pluripotent stem cells (PSCs) and mesenchymal stem cells (MSCs) as well as adenoviral, adeno-associated virus (AAV), lentiviral and other viral vectors.
We offer process development and bioassay services in addition to clinical and commercial manufacturing for cell and gene therapies, including viral vector production. We support customers at all stages of development, from process development to first-in-human trials and commercial production.
6 results found
Offerings
Cell and Gene Offerings Catalog
Latest Houston News
Sustainability